comparemela.com

Latest Breaking News On - Monday brazil - Page 19 : comparemela.com

Nas redes sociais, governadores comemoram início da vacinação nesta segunda-feira | Brasil

Nas redes sociais, governadores comemoram início da vacinação nesta segunda-feira | Brasil
ig.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ig.com.br Daily Mail and Mail on Sunday newspapers.

美媒:上海公司高层接种科兴疫苗 丧失正常行动能力

美媒:上海公司高层接种科兴疫苗 丧失正常行动能力
soundofhope.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from soundofhope.org Daily Mail and Mail on Sunday newspapers.

Vizzotti ratificó que el plan es administrar dos dosis de la Sputnik V, con un intervalo mínimo de 21 días

Vizzotti ratificó que el plan es administrar dos dosis de la Sputnik V, con un intervalo mínimo de 21 días
zonanortevision.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zonanortevision.com.ar Daily Mail and Mail on Sunday newspapers.

В России и за рубежом продолжается вакцинация «Спутником V» Новости Первый канал

В России и за рубежом продолжается вакцинация «Спутником V» Новости Первый канал
1tv.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 1tv.ru Daily Mail and Mail on Sunday newspapers.

Brazil has enough infection data to analyze Sinovac s COVID-19 vaccine - officials

By Reuters Staff 3 Min Read FILE PHOTO: A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo SAO PAULO (Reuters) - Brazil has gathered enough infection data from a late-stage trial of an experimental COVID-19 vaccine developed by China’s Sinovac Biotech and expects to have interim results on its efficiency in early December, trial organizers said on Monday. Dimas Covas, director of Butantan biomedical research institute that is running the late-stage trial of the Sinovac vaccine in Brazil, said it now has 74 confirmed cases among its trial participants, above the 61 initial milestone set for interim efficiency analysis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.